"THE TAN SHEET" CONSUMER PRODUCTS, DIETARY SUPPLEMENT/NUTRITIONALS & PHARMACEUTICAL/DIVERSIFIED STOCKS: FIRST QUARTER PERFORMANCE 1998
This article was originally published in The Tan Sheet
1See related information
You may also be interested in...
After launching in the US last year, the teriparatide product developed by Pfenex and Alvogen has been introduced in Europa, via commercialization partner Theramex, beginning with Germany.
The number of new drugs containing new active substances approved in the EU rose significantly in 2020, underpinned by a strong showing for orphan-designated products and a string of novel medicines for cancer and infectious diseases. Notable among the new clutch of approvals was the first ever COVID-19 vaccine, Pfizer/BioNTech's Comirnaty.
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.